مقاله انگلیسی رایگان در مورد مشارکت دولتی و خصوصی بیماری آلزایمر – الزویر 2018

There are greater than five million Americans living with Alzheimer’s dementia and more than 35 million people worldwide [1], and without a way to stop or slow the progression, there will be nearly a tripling of individuals affected by 2050 (13.8 million) [1]. The urgency to develop an intervention to stop or slow the progression of Alzheimer’s disease (AD) [2,3] is driving collaborations both within and between federal/governmental agencies, industrial/for-profit organizations, and nonprofit entities. Since 2013, the Alzheimer’s Association has taken the lead on working with the global nonprofit community to compile and publish compendium on the landscape of the changing landscape of private-public partnerships between these organizations and other stakeholders[4]. This compendium of global and regional private-public partnerships between governmental/federal entities, industrial/for-profit organizations, and nonprofit organizations invested in the AD research landscape was updated in 2014 [5]. Given the continuing growth of the landscape, the compendium requires update of the rapidly growing number of organizations involved, their varied goals, and their relationships with one another. The following sections include the mission statements of 25 nonprofit/charity organizations and their collaborative partnerships with governmental, global, and industrial entities, with an emphasis on the nature of collaborative efforts (i.e., improving clinical trials, obtaining and sharing data, supporting individuals with dementia and caregivers, and research funding).